🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 therapy in patients over 65 — safety and efficacy data Page 2

GLP-1 therapy in patients over 65 — safety and efficacy data

GraceAZ_72 Sun, Apr 5, 2026 at 11:59 AM 40 replies 1,293 viewsPage 2 of 8
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Apr 5, 2026 at 10:48 PM#6
PurityPaulOR said:
GraceAZ_72 said: ...mental health should only be used alongside therapy...

I read this differently from PurityPaulOR, on substance rather than tone. I would be careful about how confidently the flatness reports get attributed. Rapid weight loss, a large deficit and disrupted sleep produce low mood on their own, and separating that from a drug effect is genuinely hard.

35 5Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 32 others
Reply Quote Save Share Report
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Apr 6, 2026 at 3:04 AM#7
GraceAZ_72 said:
The weight came off and the harder part started, which is not what any of the material I read had prepared me for.

Recovering from an eating disorder and using mental health: this is a complex situation and I want to be transparent about it.

I have a history of binge eating disorder. My psychiatrist, therapist, and prescribing doctor all collaborate on my care. The GLP-1 agonist has actually been therapeutic — it removes the biological urgency of binge impulses without relying on restriction.

This is NOT appropriate for all ED patients. Anorexia, bulimia, and restrictive EDs require different approaches. But for BED specifically, the evidence and my personal experience are positive. Always involve your mental health team.

34 4AmyNC_wife, SkepticalSean, Dr.CardioMD and 31 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Apr 6, 2026 at 7:21 AM#8
JennaRN said:
I would be careful about how confidently the flatness reports get attributed.

When to call your doctor about mental health side effects — a reference I wish I'd had:

Call immediately:

  • Severe abdominal pain (could be pancreatitis)
  • Vision changes (thyroid concern)
  • Lump in neck (thyroid nodule)
  • Severe vomiting/can't keep fluids down for 24h+

Schedule an appointment:

  • Persistent nausea beyond 4 weeks
  • Significant hair loss
  • Mood changes or depression
  • Gallbladder symptoms (RUQ pain after eating)
Last edited: Apr 6, 2026 at 10:21 AM
33 3DataDave, Dr.GutHealth, amsterdam_pete and 30 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Apr 6, 2026 at 11:38 AM#9

One thing that is still open after LibrarianMeg’s answer:

What would you measure differently if you were starting again?

Last edited: Apr 6, 2026 at 1:38 PM
32 2KarenAZ_mom, zoe_NC, Dr.ObesityLA and 29 others
Reply Quote Save Share Report
GraceAZ_72
Member
156
678
Jan 2025
Tucson, AZ
Apr 7, 2026 at 8:10 AM#10

OP back with an update, since a thread like this is useless without one.

Follow-up — I put something in the gap where food used to be rather than waiting for the gap to close on its own. That was the part nobody told me.

Last edited: Apr 7, 2026 at 12:10 PM
36 9RetaRick_CA, JenPlateau, SallyK_inj and 33 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register